Saltar al contenido principal
Elsevier

Libros en Hematología

  • Updates in Pediatric Oncology, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 40-3
    • Sara Zarnegar-Lumley
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. Sara Zarnegar-Lumley brings her considerable expertise to the topic of Updates in Pediatric Oncology. Top experts provide up-to-date analyses of key topics within pediatric oncology, such as oncofertility in pediatric and adolescent patients; subsequent malignant neoplasms in childhood cancer survivors: identifying risks and screening recommendations; neurocognitive late effects among childhood cancer survivors: a holistic review of clinical risk factors; and more.

  • Haematology

    An Illustrated Colour Text
    • 5 Edición
    • Martin R. Howard + 1 más
    • Inglés
    Clear explanations, an easy-to-use logical layout, and abundant illustrations make Haematology: An Illustrated Colour Text, 5th Edition, an ideal resource for medical students, junior doctors, and others who need a concise, practical introduction to this complex subject. Part of the popular Illustrated Colour Text series, it offers a comprehensive overview of diseases of the blood presented in clear double-page learning units, with descriptions of the pathophysiological processes leading to disease and the principles of therapy. In addition, this fully updated text includes relevant anatomy, examination skills, laboratory and transfusion medicine, and practical procedures, making it an excellent learning tool at all levels of training.

  • New Developments in Hodgkin's Lymphoma, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 40-2
    • Alex F. Herrera + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Alex F. Herrera and Alison J. Moskowitz bring their considerable expertise to the topic of New Developments in Hodgkin's Lymphoma. Top experts focus on how advances in our understanding of Hodgkin’s lymphoma biology, diagnostics, and novel therapies have revolutionized the management of Hodgkin’s lymphoma.

  • Updates in Surgical Oncology, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 40-1
    • Jeffrey D. Wayne
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. Jeffrey D. Wayne brings his considerable expertise to the topic of Updates in Surgical Oncology. Top experts discuss neoadjuvant treatment strategies in gastrointestinal stromal tumors; hepatic artery infusion pump therapy in unresectable and resectable liver tumors; contemporary approaches to adrenocortical carcinoma; contemporary management of dermatofibrosarcoma protuberans; and much more.

  • Updates in Gynecologic Oncology, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 39-6
    • Dario R. Roque
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. Dario R. Roque brings his considerable expertise to the topic of Updates in Gynecologic Oncology. Top experts provide in-depth perspectives on key topics such as emerging therapeutic targets for platinum-resistant ovarian cancer; sexual health following diagnosis and treatment of gynecologic cancer; antibody–drug conjugates for the treatment of gynecologic cancer; surgery for recurrent ovarian cancer; and many more.

  • Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 39-5
    • Jennifer R. Brown︎ + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Jennifer R. Brown and Matthew S. Davids bring their considerable expertise to the topic of Chronic Lymphocytic Leukemia. Top experts provide in-depth perspectives on CLL, including basic biology, frontline and relapsed refractory treatments, mechanisms of resistance to targeted therapies, Richter’s transformation, and some of the common complications of the disease stemming from immune dysfunction—offering a state-of-the-art overview of the field to help optimize the care of patients with CLL.

  • Sarcomas, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 39-4
    • Suzanne George
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Suzanne George and Alberto S. Pappo bring their considerable expertise to the topic of Sarcomas. Top experts focus on key elements of the multi-disciplinary approach to diagnosis, emerging biomarkers and therapeutics, local therapy and systemic approaches to sarcomas - not only the most common subtypes, but also ultra-rare sarcoma histologies which impact pediatric and adult patients.

  • Hemophagocytic Syndromes, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 39-3
    • Nancy Berliner + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Nancy Berliner and Barbara A. Degar bring their considerable expertise to the topic of Hemophagocytic Syndromes. Top experts provide in-depth perspectives on these uncommon but potentially life-threatening disorders, including pathology of histiocytic disorders, genomic alterations in LCH, immunopathology of HLH, clinical characteristics and treatment of familial HLH, and much more.

  • Hematología. Manual básico razonado

    • 6 Edición
    • Fermín Sánchez-Guijo + 1 más
    • Español
    Esta sexta edición, totalmente actualizada, pone especial énfasis en las nuevas clasificaciones de las neoplasias hematológicas elaboradas en 2022 (la clásica de la OMS y la International Consensus Classification,) y en los recientes hallazgos moleculares con implicaciones para el diagnóstico, el pronóstico y/o el tratamiento de las enfermedades de la sangre. Entre las novedades terapéuticas destacan la consolidación de la inmunoterapia en sus nuevas indicaciones, especialmente con los nuevos anticuerpos monoclonales biespecíficos, los anticuerpos inmunoconjugados y la terapia celular adoptiva con linfocitos T con receptor de antígeno quimérico. Además, se presentan los nuevos tratamientos de terapia génica aprobados para enfermedades hereditarias no neoplásicas como la anemia falciforme, la betatalasemia o la hemofilia. Se mantienen los resúmenes introductorios, que recogen los aspectos más importantes de cada capítulo, junto con las llamadas al margen, que destacan datos clave. Como en ediciones previas, se han resaltado y actualizado aquellos contenidos de reiterada aparición en el examen MIR. Las numerosas referencias cruzadas a lo largo del texto mantienen la uniformidad y la interrelación del contenido para transmitir un bloque de conocimientos integrado. Esta obra se ha consolidado a lo largo de los últimos 25 años entre los estudiantes españoles e hispanoamericanos de Medicina y Ciencias Biomédicas por su formato diferencial, basado en la formulación de los contenidos básicos de la hematología en forma de preguntas directas, eminentemente prácticas, seguidas de respuestas razonadas. Es también especialmente atractiva para profesionales biomédicos en formación y residentes de las diversas especialidades médicas.

  • Innovation and Emerging Technologies in Radiation Oncology, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 39-2
    • Dukagjin Blakaj + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Dukagjin Blakaj and Mauricio Gamez bring their considerable expertise to the topic of Innovation and Emerging Technologies in Radiation Oncology. Top experts cover key topics such as FLASH radiation therapy; biomarker driven treatment algorithms in radiation oncology; spatial fractionated radiation therapy (SFRT): mini beam applications in radiation oncology; microbiome and effects on oncology treatments; and many more.

  • Management of Metastatic Liver Tumors, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 39-1
    • Michael D'Angelica
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. Michael D’Angelica brings his considerable expertise to the topic of Management of Metastatic Liver Tumors. Top experts cover key topics such as surgical management of colorectal cancer liver metastases, breast cancer liver metastasis, and neuroendocrine tumor liver metastases; surgical management of sarcoma metastatic to liver; surgical management of gynecologic cancers; and many more.

  • Cutaneous Oncology, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 38-5
    • David E. Fisher
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide information on skin structure, function, and immunology, then offer overviews of the therapeutic state of the art for both melanoma and non-melanoma skin cancers. Discussions focus on unique clinical challenges and biological breakthroughs which have come to light in recent studies of cutaneous malignancies.

  • Cancer Precursor Conditions and their Detection, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 38-4
    • Elizabeth K. O'Donnell
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. Elizabeth K. O'Donnell brings her considerable expertise to the topic of Cancer Precursor Syndromes and Their Detection. Top experts focus on cancer precursors for different sites, with articles on the risk-benefit analysis of early interception; plasma cell precursors; early detection and interception of lung cancer, cervical cancer, GI cancers, skin cancer; and head and neck cancer; biomarkers and early detection; and more.

  • Malignancies of the Upper Gastrointestinal Tract, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 38-3
    • David H. Ilson
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor David H. Ilson brings his considerable expertise to the topic of Malignancies of the Upper GI Tract.

  • New Developments in Myeloma, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 38-2
    • Peter Leif Bergsagel
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. P. Leif Bergsagel brings his considerable expertise to the topic of New Developments in Myeloma. With the advent of next generation sequencing and immune profiling technologies, marked advances have been made recently in the understanding of the molecular and immune pathogenesis of multiple myeloma. Yet even with these advances, there is a continual search for new therapeutic approaches. In this issue, top experts discuss a full range of clinically relevant topics in this complex and fast-changing field.

  • Global Oncology: Disparities, Outcomes and Innovations Around the Globe, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 38-1
    • Mary D. Chamberlin
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Mary D. Chamberlin and Narjust Duma bring theirconsiderable expertise to the topic of Global Oncology: Disparities, Outcomes and Innovations Around the Globe. The first section of this issue is non-disease site-specific, covering broad topics that influence global health and oncology in various world regions, such as disparities, political unrest, the role of ASCO and ICEC and other organizations for education and research collaborations, access to training and innovations, etc. The second section is disease site-specific (lung, CNS, lymphoma, etc.), addressing approaches to prevention, access to treatment, survivorship, palliative care, and more.

  • CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 37-6
    • Caron A Jacobson + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Caron A. Jacobson and Parth S. Shah bring their considerable expertise to the topic of CAR T-Cell Therapy. Top experts in the field discuss the multiple ways CAR T-cell therapy can be used to help fight a variety of cancers, such as diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, mantle cell lymphoma, multiple myeloma, and B-cell acute lymphoblastic leukemia (ALL).

  • Renal Cell Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 37-5
    • Bradley A. Mcgregor + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more.

  • Waldenström Macroglobulinemia, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 37-4
    • Jorge J Castillo + 2 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Jorge J. Castillo, Prashant Kapoor, and Shayna Sarosiek bring their considerable expertise to the topic of Waldenström Macroglobulinemia. Top experts in the field provide a focused update on the biology, diagnosis and management, and novel therapies for patients with Waldenström macroglobulinemia, a rare blood cell cancer characterized by an excess of abnormal white blood cells in the bone marrow.

  • Lung Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 37-3
    • Sarah B. Goldberg + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Sarah B. Goldberg and Roy S. Herbst bring their considerable expertise to the topic of Lung Cancer. Top experts in the field cover key topics such as state-of-the-art pathologic and molecular testing; neoadjuvant vs. adjuvant therapy for early-stage NSCLC; new therapies on the horizon (immunotherapy, ADCs, etc.); supportive care and symptom management; smoking cessation; and more.

  • Thalassemia, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 37-2
    • Edward J. BenzJr + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Edward J. Benz, Jr. and Vijay G. Sankaran bring their considerable expertise to the topic of Thalassemia. Top experts in the field provide an overview of the history, epidemiology, pathogenic mechanisms, and clinical management of the thalassemia syndromes.

  • Breast Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 37-1
    • Harold J. Burstein
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor Dr. Harold J. Burstein brings his considerable expertise to Breast Cancer. Top experts provide a comprehensive update on multidisciplinary management of early- and late-stage breast cancer, including key topics such as global perspectives on the epidemiology and treatment of breast cancer; breast cancer pathology in the era of genomics; optimizing radiation therapy after breast conserving surgery; and more.

  • Sickle Cell Syndromes, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 36-6
    • Sophie Lanzkron + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy: reproductive health; chronic pain; and more.

  • Hematology

    Basic Principles and Practice
    • 8 Edición
    • Ronald Hoffman + 5 más
    • Inglés
    **Selected for 2026 Doody's Core Titles in Hematology/Oncology*... revised, comprehensive content from leading global contributors ensures that Hematology, 8th Edition, remains your #1 choice for expert guidance in all areas of this rapidly advancing subspecialty. This edition reflects the numerous advances that are redefining the field and dramatically influencing new approaches to diagnosis, treatment, and outcomes. Well-illustrated and clinically focused, it details the basic science and clinical practice of hematology and hematopoietic cellular therapy—covering virtually all aspects of hematology in one definitive resource.

  • Pancreatic Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 36-5
    • Matthew B. Yurgelun + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Matthew B. Yurgelun and Douglas A. Rubinson bring their considerable expertise to the topic of Pancreatic Cancer. Top experts in the field cover key topics such as pancreatic adenocarcinoma: trends in epidemiology, risk factors, and outcomes; decision making regarding perioperative therapy in individuals with localized pancreatic adenocarcinoma; the evolving role of radiotherapy in the management of individuals with pancreatic adenocarcinoma; and more.

  • Gene-Based Therapies for Pediatric Blood Diseases, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 36-4
    • Nirali N. Shah + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Sung-Yun Pai and Nirali N. Shah bring their considerable expertise to the topic of Gene-Based Therapies for Pediatric Blood Diseases. Top experts in the field cover key topics such as CAR T-cell therapy: current status; engineered T cells; NK-cell therapy; hemoglobinopathies: beta-thalassemia, sickle cell disease; hemophilia A/B; primary immunodeficiencies; and more.

  • Colorectal Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 36-3
    • Kimmie Ng + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Kimmie Ng and Benjamin L. Schlechter bring their considerable expertise to the topic of Colorectal Cancer. Despite tremendous progress in the management of this disease, many questions and controversies remain regarding screening, adjuvant therapy for resected colon cancers, targeted therapies and immunotherapy for patients with advanced disease, surgical management, and more. In this issue, top experts in the field address provide clinicians with the tools to individualize management and optimize care for this growing patient population.

  • New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 36-2
    • Alexandra P. Wolanskyj-Spinner + 1 más
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editors Drs. Alexandra P. Wolanskyj-Spinner and Ronald S. Go bring their considerable expertise to the topic of New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia. Top experts in the field cover key topics such as warm AIHA; cold AIHA; drug-induced AIHA; adult Evans syndrome; immunotherapy-associ... AIHA; complications of AIHA; and more.

  • Blood Tests Made Easy

    • 1 Edición
    • Paul Hamilton
    • Inglés
    Blood Tests Made Easy is a quick reference guide designed to bring medical students up to speed when interpreting blood tests on their clinical placements.Small enough to be carried and quickly referenced on the go, this book covers everything you need to know when interpreting bloods, including the main abnormalities you are likely to encounter. Rather than focusing on theory or physiology, it is designed to provide an easy-to-follow guide to support clinical decision making.This latest addition to the Made Easy series will fill knowledge gaps on blood test interpretation, becoming a valuable asset both for medical students and, later, as a reference guide to increase junior doctors’ confidence on the wards.

  • Diagnostic Pathology: Spleen

    • 2 Edición
    • Aaron Auerbach + 1 más
    • Inglés
    This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all areas of splenic pathology, it incorporates the most recent clinical, pathologic, and molecular knowledge in this challenging field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, the 2nd edition of Diagnostic Pathology: Spleen is a one-stop reference for accurate, complete pathology reports, ideal as a day-to-day reference or as a reliable training resource.

  • Manual de las toxicidades relacionadas con el tratamiento del cáncer

    • 1 Edición
    • Vamsidhar Velcheti + 1 más
    • Español
    Un recurso conciso y específico que aborda un aspecto esencial para la asistencia óptima de los pacientes con cáncer. Los autores se aproximan de forma sencilla al manjeo de los síntomas y las toxicidades derivadas del tratamiento del cáncer mediante un formato práctico y de fácil consulta, que permite encontrar la información con rapidez y comodidad. Abarca los tratamientos sistémicos y de radiación, como la quimioterapia, la inmunoterapia, las terapias dirigidas y la radioterapia, detallando los síntomas de cada toxicidad para ofrecer un tratamiento específico. Presenta temas clave como el tratamiento de las reacciones infusionales, cuándo se requiere una biopaisa y las dificultades específicas que plantean las nuevas inmunoterapias, repasa los enfoques farmacológicos y no farmacológicos del manejo de los síntomas y ofrece recomendaciones para atenuar las toxicidades en pacientes de alto riesgo.

  • Central Nervous System Malignancies, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 36-1
    • David A. Reardon
    • Inglés
    In this issue of Hematology/Oncology Clinics, guest editor David A. Reardon︎ brings his considerable expertise to the topic of Central Nervous System Malignancies. Top experts in the field cover key topics such as CNS Metastases, Leptomeningeal Disease, Neurofibromatoses, Imaging Advances for CNS Tumors, and more.

  • Inherited Bleeding Disorders, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 35-6
    • Nathan T. Connell︎
    • Inglés

  • Head and Neck Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 35-5
    • Glenn J. Hanna
    • Inglés
    This issue of Hematology/Oncology Clinics, guest edited by Dr. Glenn J. Hanna, will focus on Head and Neck Cancer. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. This issue addresses the evaluation and management of the complex head and neck cancer patient with articles focused on unique epidemiology and therapeutic principles by subsite of disease. Additional information relevant to rare head and neck malignancies is included. The issue further focuses on the evolving applications of minimally invasive surgery in oropharynx cancer and the role of immunotherapy in the management of advanced disease. Topics include: Radiologic Evaluation of the Head and Neck Cancer Patient, Robotic and Endoscopic Approaches to Head and Neck Surgery, Cancer of the Oral Cavity and Lip, Cancer of the Oropharynx and the Association with Human Papillomavirus, Cancer of the Larynx and Hypopharynx, Cancer of the Nasal Cavity and Paranasal Sinuses, Cancer of the Nasopharynx and the Association with Epstein-Barr Virus, Salivary Glands Cancers, Thyroid and Parathyroid Cancers, Cutaneous Malignancies of the Head and Neck, Managing Recurrent and Metastatic Head and Neck Cancer, and Immunotherapy for Head and Neck Cancer.

  • Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 35-4
    • Jennifer R. Brown︎
    • Inglés
    This issue of Hematology/Oncology Clinics, guest edited by Dr. Jennifer R. Brown︎, will focus on Chronic Lymphocytic Leukemia. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Chronic Lymphocytic Leukemia: Do We Know the Cell of Origin Yet?; Significance of BCR Stereotypy; Prognostic and Predictive Implications of Cytogenetics and Genomics; Role of Epigenetics in Chronic Lymphocytic Leukemia; Genomics of Resistance to Targeted Therapies; First Line Therapy for Chronic Lymphocytic Leukemia; The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia Therapy; BTK Inhibitors; Minimal Residual Disease; Should Undetectable MRD Be the Goal of Chronic Lymphocytic Leukemia Therapy?; Management of Chronic Lymphocytic Leukemia after Progression on BTK Inhibitors; Role of PI3K Inhibitors in Chronic Lymphocytic Leukemia; Can We Restore the Immunodeficiency of Chronic Lymphocytic Leukemia?; and Immune Therapy for Chronic Lymphocytic Leukemia

  • Bladder Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 35-3
    • Guru P. Sonpavde
    • Inglés
    This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Guru P. Sonpavde, is devoted to Bladder Cancer. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: Epidemiology of bladder cancer, The molecular biology of bladder cancer and potential implications for therapy, Current therapy for metastatic urothelial carcinoma, Current perioperative therapy for muscle invasive urothelial carcinoma, Current therapy and emerging intravesical agents to treat non-muscle invasive bladder cancer, Diagnosis and staging of bladder and upper tract urothelial cancer, Surgery for bladder and upper tract urothelial cancer, Bladder conserving therapy for muscle invasive bladder cancer: opportunities to incorporate molecular profiling, Emerging immunotherapy for bladder cancer, Emerging targeted therapy for bladder cancer, Real world outcomes of patients with bladder cancer, Preclinical systems to develop bladder cancer therapeutics, Developing precision medicine for bladder cancer, and Future Directions in Bladder Cancer Treatment and Research.

  • Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 35-2
    • John Mascarenhas + 3 más
    • Inglés
    This issue of Hematology/Oncology Clinics, guest edited by Drs. Ronald Hoffman, Ross Levine, John Mascarenhas, and Raajit Rampal, is dedicated to Myeloproliferative Neoplasms. This issue is one of six selected each year by the series consulting editors, Drs. George P. Canellos and Edward J. Benz. Topics in this issue include—but are not limited to— Overview of pathophysiology and potential drug targets, The role of the megakaryocyte, Epigenetics, Genetics, Novel technologies for understanding MPN biology, Important pathology considerations, Current Clinical investigations, Quality of life, Application of stem cell therapy, Immunotherapy approaches, Clinical unmet needs in ET/PV, Accelerated and blast phase MPNs, Epidemiology, Thrombotic and hemorrhagic complications, Murine modeling, The microenvironment in MPNs, MDS/MPN overlap syndrome, and Advancing effective clinical trial designs.

  • Melanoma, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 35-1
    • F. Stephen Hodi
    • Inglés
    This issue of Hematology/Oncology Clinics, Guest Edited by F. Stephen Hodi, is devoted to Melanoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: State of Melanoma, Biology of Melanoma, Epidemiology of Melanoma, Surgical Management of Melanoma, Melanoma Adjuvant Therapy, Targeted Therapies for Melanoma, Non-cutaneous Melanomas, Immune Checkpoint Therapies for Melanoma, Resistance Mechanisms to Current Therapies, Cellular Therapy and Cytokine Treatments for Melanoma, Combinatorial Approaches to the Treatment of Melanoma, and Melanoma Future Directions.

  • Systemic Amyloidosis due to Monoclonal Immunoglobulins, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 34-6
    • Raymond L. Comenzo
    • Inglés
    This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Raymond L. Comenzo, is devoted to Systemic Amyloidosis due to Monoclonal Immunoglobulins. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: The Spectrum of Monoclonal Immunoglobulin Diseases, Systemic Amyloidosis due to Clonal Plasma Cell Diseases, Systemic Amyloidosis due to Low-grade Lymphomas, The Process of Amyloid Formation due to Monoclonal Immunoglobulins, Cardiac Involvement, Renal Involvement, Liver and Gastrointestinal Involvement, Peripheral Nervous System Involvement, Options for Chemotherapy, Stem-cell Mobilization and Autologous Transplant, Monoclonal Antibody Therapies, Solid Organ Transplant, Supportive Care, Patient Voices, and Future Perspectives.

  • Mantle Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 34-5
    • John P. Leonard
    • Inglés
    This issue of Hematology/Oncology Clinics, Guest Edited by Dr. John P. Leonard, is devoted to Mantle Cell Lymphoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Topics discussed in this important issue include: Molecular pathogenesis of Mantle Cell Lymphoma; MCL and cell cycle dysregulation; Heterogeneity in MCL biology and outcomes; Watch and wait in mantle cell lymphoma; Limited stage mantle cell lymphoma; Initial and consolidation therapy for younger patients with MCL; Approach to the initial treatment of older patients with MCL; Current and future approaches to the use of minimal residual disease monitoring in the treatment of patients with MCL; Bruton’s Tyrosine Kinase inhibitors for treatment of Mantle Cell Lymphoma; BTKi resistance in MCL; Blastoid MCL; Allogeneic transplant and CAR-T cell therapy in MCL; Quality of life considerations and chronic therapy in management of patients with MCL; and Key clinical and translational research questions.

  • Atlas of Diagnostic Hematology

    • 1 Edición
    • Mohamed E. Salama
    • Teruya-Feldstein Julie + 1 más
    • Inglés
    Ideal as a quick, easy-to-use reference in the laboratory or clinical setting, Atlas of Diagnostic Hematology is an abundantly illustrated guide to the vast range of malignant and non-malignant disorders of the blood. More than 1,200 vibrant, full-color images enable you to identify and compare the unique clinical and histologic features of various blood disorders and confidently reach a diagnosis. Coverage includes photos of actual cases that span the entire range of this complex field, including rare conditions and difficult diagnoses.

  • Follicular Lymphoma, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 34-4
    • Jonathan W Friedberg
    • Inglés
    This issue of Hematology/Oncology Clinics, Guest Edited by Dr. Jonathan W. Friedberg, is devoted to Follicular Lymphoma. This issue is one of six selected each year by our series Consulting Editors, George P. Canellos and Edward J. Benz. Articles in this important issue include: Epidemiology of Follicular Lymphoma, Pathogenesis of Follicular Lymphoma, Circulating tumor DNA and MRD assessment in Follicular Lymphoma, Clinical and biological prognostic factors in Follicular Lymphoma, Vitamin D and Follicular Lymphoma, Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma, Initial Treatment of High Tumor Burden Follicular Lymphoma, Maintenance Antibody Therapy of Follicular Lymphoma, Cellular Therapy in Follicular Lymphoma, Immunomodulatory Agents in Follicular Lymphoma, Phosphoinositide 3-Kinase Inhibition in Follicular Lymphoma, Novel Agents Beyond Immunomodulatory Imide Drugs and Phosphoinositide 3-Kinases for Follicular Lymphoma, Early progression of Follicular Lymphoma, Biological Basis of Histological Transformation, and Treatment of Histological Transformation.

  • Blastic Plasmacytoid Dendritic Cell Neoplasm, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 34-3
    • Andrew A. Lane
    • Inglés
    This issue of Hematology/Oncology Clinics, guest edited by Andrew A. Lane, will cover Blastic Plasmacytoid Dendritic Cell Neoplasm. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue include: Clinical Presentation and Pathology, Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA mutations and epigenetics, Cytogenetics of Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm Chemotherapy, CD123 and Leukemia Stem Cells, Tagraxofusp for Blastic Plasmacytoid Dendritic Cell Neoplasm, Immune Therapies Targeting CD123 in Blastic Plasmacytoid Dendritic Cell Neoplasm, Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm in Children, European Perspective, Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm, and Social Media in Blastic Plasmacytoid Dendritic Cell Neoplasm and Other Rare Diseases.

  • Myelodysplastic Syndromes, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 34-2
    • David Steensma
    • Inglés
    This issue of Hematology/Oncology Clinics, guest edited by David P. Steensma, will cover key topics in Myelodysplastic Syndromes. This issue is one of six selected each year by our series consulting editors, George P. Canellos and Edward J. Benz. Topics discussed in this issue will include: Novel prognostic models for MDS, Evaluating MDS patients with genetic mutations that might be germline, Implications of splicing mutations in MDS for pathophysiology and therapy, Assessing quality of life in MDS/MPN overlap patients, Creation of a clinic for patients with clonal hematopoiesis, Luspatercept in MDS, Prospects for venetoclax in MDS, Treatment of acquired sideroblastic anemias, Treatment of patients with AML arising from MDS, Targeting TP53 mutations in MDS, among others.

  • Contemporary Topics in Radiation Medicine, Part II: Disease Sites, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 34-1
    • Ravi A. Chandra + 2 más
    • Inglés
    This issue of Hematology/Oncology Clinics, guest edited by Ravi A. Chandra, Lisa A. Kachnic, and Charles R. Thomas, Jr., is the second volume of Contemporary Topics in Radiation Medicine, with focus on Disease Sites. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. Topics discussed in this issue will include: Breast, Central Nervous System, GI, Genitourinary/Prosta... Gynecologic, Head & Neck, Thoracic, Hematologic cancers (including Leukemias, Lymphomas), Pediatric Cancer, Sarcoma/STS, Skin, Oligometastatic Disease, Palliation & Supportive Care & Inpatient Medicine, Radiation Emergencies, among others.

  • Immunotherapy in Cancer, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 33-2
    • Patrick A Ott
    • Inglés
    This issue of Hematology/Oncology Clinics, guest edited by Patrick A. Ott, will focus on Immunotherapy in Cancer. Topics include, but are not limited to, Cancer Vaccines, Innate Immune stimulation, Costimulatory and Agonistic Antibodies, Immune modulation with radiation, Oncolytic virus therapy, Cytokine Therapy, Adoptive T cell transfer, Immune related toxicity, and Immune checkpoint combinations.

  • Risk Management in Transfusion Medicine

    • 1 Edición
    • J. Mills Barbeau
    • Inglés
    Get a quick, expert overview of risk management in transfusion medicine from Dr. James Mills Barbeau. This practical resource presents a summary of today’s state-of-the-art techniques for reducing harm during all phases of transfusion practice, including blood collection, testing, processing, clinical assessment, and transfusion. It’s an easy-to-read, one-stop resource for managing and mitigating the various levels of risk in a variety of transfusion settings and scenarios.

  • Waldenström Macroglobulinemia, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 32-5
    • Jorge J Castillo + 2 más
    • Inglés
    This issue of Hematology/Oncology Clinics, edited by Drs. Jorge J. Castillo, Efstathios Kastritis, and Steven P. Treon, will focus on Waldenström Macroglobulinemia. Topics include, but are not limited to, Genomics; Epigenomics; Flow cytometry; Marrow microenvironment; Familial Waldenstrom; MYD88 L265P and other MYD88 mutations; CXCR4 and other recurrent mutations; Diagnosis and differential diagnosis; Criteria to treat and treatment goals; Alkylators; Monoclonal antibodies; Proteasome inhibitors; BTK inhibitors; Transplant; and Novel approaches.

  • Consultative Hemostasis and Thrombosis

    • 4 Edición
    • Craig S. Kitchens + 2 más
    • Inglés
    With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that’s new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors’ position that correct treatment begins with correct diagnosis. This trusted resource by Drs. Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, Michael B. Streiff, and David A. Garcia is designed for rapid reference and critical decision making at the point of care.

  • Thalassemia, An Issue of Hematology/Oncology Clinics of North America

    • 1 Edición
    • Volumen 32-2
    • Ali Taher
    • Inglés
    This issue of Hematology/Oncology Clinics, edited by Dr. Ali Taher, focuses on Thalassemia. Topics include, but are not limited to, Molecular basis and genetic modifiers; Evolving spectrum of epidemiology; Clinical classification; Ineffective erythropoiesis, anemia and iron overload; Hypercoagulability and vascular disease; Clinical complications and their management; Transfusion and iron chelation therapy; Hematopoietic Stem Cell Transplantation in Thalassemia; Gene therapy and genome editing; Emerging therapies; Quality of life; Advances in understanding pathophysiology and treatment of fertility, pregnancy, and prenatal diagnosis in Thalassemia; and MRI for iron overload.